- Home
- RVPH vs BCG Comparison
RVPH vs BCG Comparison
Compare RVPH & BCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- BCG
- Stock Information
- Founded
- RVPH 2006
- BCG 2016
- Country
- RVPH United States
- BCG United States
- Employees
- RVPH N/A
- BCG N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- BCG
- Sector
- RVPH Health Care
- BCG
- Exchange
- RVPH Nasdaq
- BCG Nasdaq
- Market Cap
- RVPH 30.1M
- BCG 32.5M
- IPO Year
- RVPH N/A
- BCG N/A
- Fundamental
- Price
- RVPH $0.40
- BCG $1.69
- Analyst Decision
- RVPH Strong Buy
- BCG
- Analyst Count
- RVPH 5
- BCG 0
- Target Price
- RVPH $5.20
- BCG N/A
- AVG Volume (30 Days)
- RVPH 1.3M
- BCG 24.3K
- Earning Date
- RVPH 11-13-2025
- BCG 11-13-2025
- Dividend Yield
- RVPH N/A
- BCG N/A
- EPS Growth
- RVPH N/A
- BCG N/A
- EPS
- RVPH N/A
- BCG N/A
- Revenue
- RVPH N/A
- BCG $173,961,000.00
- Revenue This Year
- RVPH N/A
- BCG N/A
- Revenue Next Year
- RVPH N/A
- BCG N/A
- P/E Ratio
- RVPH N/A
- BCG N/A
- Revenue Growth
- RVPH N/A
- BCG 7.45
- 52 Week Low
- RVPH $0.30
- BCG $1.45
- 52 Week High
- RVPH $4.28
- BCG $6.55
- Technical
- Relative Strength Index (RSI)
- RVPH 34.75
- BCG 41.63
- Support Level
- RVPH $0.50
- BCG $1.75
- Resistance Level
- RVPH $0.47
- BCG $2.10
- Average True Range (ATR)
- RVPH 0.03
- BCG 0.14
- MACD
- RVPH -0.01
- BCG -0.02
- Stochastic Oscillator
- RVPH 14.30
- BCG 36.92
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About BCG Binah Capital Group Inc. Common Stock
Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.